4 ms·

What's stopping revocation of approval? Or is that fixed in stone now?

• chews 5y ago
  Stock prices mostly
• phnofive 5y ago
  The manufacturer, Biogen, is ordered to continue studying the efficacy of the drug as a condition of approval. The results of this continued investigation are due in - seriously - nine years. Meanwhile, anyone with any stage the disease will receive treatment; fortunately (?), Medicare is expected to bear the burden of this expense.